![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1663397
¼¼°èÀÇ ÆÞ½º ÀüÀÚ±âÀå Ä¡·á±â ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼®(Ãâ·Âº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°)°ú ¿¹Ãø(2022-2032³â)Global Pulse Electromagnetic Field Therapy Devices Market Size study, by Power (Low Frequency, High Frequency), by Application (Pain Management, Bone Growth, Others), by End-use (Hospitals, Home Care Settings, Others), and Regional Forecasts 2022-2032 |
¼¼°è ÆÞ½º ÀüÀÚ±âÀå Ä¡·á±â ½ÃÀåÀº 2023³â¿¡ 5¾ï 2,340¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.0% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºñħ½ÀÀû, ºñ¾à¹°Àû ÅëÁõ °ü¸® ¹× ȸº¹À» À§ÇÑ ºñħ½ÀÀû Á¢±Ù¹ýÀ¸·Î PEMF Ä¡·áÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î ±â±âÀÇ ¹ßÀüÀ¸·Î PEMF Ä¡·á´Â ´Ù¾çÇÑ È¯ÀÚÃþ¿¡°Ô ´õ¿í Ä£¼÷ÇÏ°Ô ´Ù°¡°¥ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
ÄÄÆÑÆ®ÇÏ°í ¼ÒÇüÈµÈ µðÀÚÀΰú °ÈµÈ ¹èÅ͸® ¼ö¸í µîÀÇ ±â¼ú Çõ½ÅÀº PEMF ±â±âÀÇ »ç¿ë ÆíÀǼºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ¯Â¡Àº ¿ø°Ý ÀÇ·á Ç÷§Æû°úÀÇ ÅëÇÕ°ú ÇÔ²² ÀçÅÃÄ¡·áÀÇ ÆíÀǼºÀ» ³ô¿© ¿ø°Ý ÀÇ·á ¼Ö·ç¼ÇÀÇ È®´ë Ãß¼¼¿¡ ºÎÇÕÇÕ´Ï´Ù.
°üÀý¿°, °ñ´Ù°øÁõ, ¼¶À¯±ÙÀ°Åë°ú °°Àº ¸¸¼º ÁúȯÀÇ ±ÞÁõÀº È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁõÆø½Ã۰í ÀÖÀ¸¸ç, PEMF Àåºñ´Â ÀÌ·¯ÇÑ ÁúȯÀÇ Áõ»óÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ÀÎÁ¤¹Þ¾Æ ´ëü Ä¡·á °æ·Î¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ±Ù°ñ°Ý°è Áúȯ°ú ¸¸¼º ÅëÁõ¿¡ Ãë¾àÇÑ ¼¼°è Àα¸ÀÇ °í·ÉÈ´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, À̴ źźÇÑ ÀÇ·á ÀÎÇÁ¶ó¿Í ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µÆ½À´Ï´Ù. ±× µÚ¸¦ À̾î À¯·´ÀÌ ¸¸¼ºÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ ³ôÀº äÅ÷üÀ» º¸À̰í ÀÖ½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÀÎÇÁ¶ó °³¼±°ú PEMF Ä¡·áÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ½ÃÀåÀº ¶ÇÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ÀÓ»ó °ËÁõ Áõ°¡·Î ÀÎÇØ ¼öÇý¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, PEMF Àåºñ´Â ºñÀ¯ÇÕ °ñÀý ¹× °ñ°üÀý¿°°ú °°Àº Áúȯ¿¡ ´ëÇÑ FDA ½ÂÀÎÀ» ¹Þ¾Æ Ä¡·á È¿°ú¸¦ °Á¶Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷µéÀÌ Áö¼ÓÀûÀ¸·Î ±â¼ú Çõ½Å°ú Àü·«Àû Á¦ÈÞ¸¦ ÃßÁøÇϰí ÀÖ´Â °Íµµ ½ÃÀå ºÐÀ§±â¸¦ ´õ¿í °íÁ¶½Ã۰í ÀÖ½À´Ï´Ù.
The Global Pulse Electromagnetic Field Therapy Devices Market, valued at USD 523.4 million in 2023, is anticipated to grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2032. The increasing adoption of PEMF therapy for its non-invasive, drug-free approach to pain management and recovery has been a significant factor driving market expansion. With advancements in portable and user-friendly devices, PEMF therapy has become more accessible to diverse patient demographics.
Technological innovations such as compact, miniaturized designs and enhanced battery life have bolstered the usability of PEMF devices. These features, coupled with integration into telemedicine platforms, offer increased convenience for home-based care, aligning with the growing trend of remote healthcare solutions.
The surge in chronic conditions like arthritis, osteoporosis, and fibromyalgia has amplified the demand for effective therapeutic options. PEMF devices are recognized for their ability to manage symptoms of these conditions, providing alternative treatment pathways. Additionally, the aging global population, prone to musculoskeletal disorders and chronic pain, further fuels market growth.
Regionally, North America led the market in 2023, driven by a robust healthcare infrastructure and significant technological advancements. Europe followed closely, with high adoption rates owing to the prevalence of chronic disorders. Meanwhile, the Asia Pacific region is projected to experience the fastest growth, supported by improving healthcare infrastructure and heightened awareness of PEMF therapy benefits.
The market also benefits from regulatory approvals and increased clinical validation. For example, PEMF devices have been FDA-approved for non-union fractures and other conditions like osteoarthritis, emphasizing their therapeutic efficacy. The ongoing efforts of key market players in innovation and strategic collaborations further enhance the market landscape.